Henrijette Richter in

Henrijette Richter

Login to view DISC.
Board Member at Mozart Therapeutics, Inc
📍 Copenhagen, Capital Region of Denmark, Denmark

Henrijette Richter is a Managing Partner at Sofinnova Partners, where she specializes in early-stage biotech and medtech investments. A scientist by training, she holds a Ph. D. in Molecular Biology from the University of Copenhagen and completed a postdoctoral fellowship at MIT. Before Sofinnova, she was instrumental in founding and building the venture firm Novo Seeds.

Henrijette transitioned from academic research to venture capital after observing the high-stress environment at MIT was not for her. She advocates for finding a career that brings happiness and keeping options open. She is a mother and has spoken about the importance of maintaining her individual identity while balancing work and family life.

Early in her venture capital career, she faced a crisis of confidence, feeling she didnt understand the financial discussions, and almost returned to science before persevering.

Read the full overview →
Experience
18 Years
Current Role
Board Member
Location
Copenhagen, Capital Region of Denmark, Denmark
Personality Overview

How Henrijette shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Henrijette cares about

Early-Stage Investing
Her role is focused on Sofinnova's flagship fund for early-stage investments in biotech and medtech, guiding companies from their initial phases.
Therapeutics Development
She holds board seats at multiple therapeutics companies, including Mozart Therapeutics and Nitrase Therapeutics, reflecting her focus on developing novel treatments.
+5 more topics Login to view topics
Career

Work history

9-2021
Board Member
Mozart Therapeutics, Inc
7-2021
Board Member
Muna Therapeutics
4-2020
Board Member
Nitrase Therapeutics
9-2019
Board Member
Twentyeight-Seven Therapeutics
9-2019
Member of The Supervisory Board
iOmx Therapeutics AG
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2008 - 2008
executive course
Harvard Business School
2005 - 2006
Executive Certificate
Copenhagen Business School
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Henrijette. Free, 10 seconds.